ASCO 2007

Markus Heiss REFERENCE: ABSTRACT 5001, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 MARKUS HEISS, Klinikum Cologne, Merheim For patients with malignant ascites as a

Volker Diehl George Canellos Hodgkin’s Disease: 10-Year Results Show Further Benefit From Escalated BEACOPP Therapy REFERENCE: Abstract 8015, ASCO Annual Meeting Chicago June 1-5, 2007 VOLKER DI

Christian Manegold Roy Herbst More Support for Bevacizumab in Advanced Lung Cancer REFERENCE: Abstract LBA7514, ASCO Annual Meeting Chicago June 1-5, 2007 CHRISTIAN MANEGOLD, Heidelberg University, Ma

Aimery de Gramont Robert Mayer MOSAIC Study Six Year Results: Adjuvant Oxaliplatin Adds Survival Advantage for Patients with Stage III Colorectal Cancer REFERENCE: 4007, ASCO Annual Meeting Chicago Ju

Josep Llovet Robert Mayer Sorafenib The ‘New Standard’ for Advanced Liver Cancer REFERENCE: ABSTRACT 5 (Plenary Session), ASCO Annual Meeting Chicago June 1-5, 2007 JOSEP LLOVET, IDIBAPS H

Bernard Escudier Dean Bajorin Bevacizumab in Advanced Kidney Cancer: Another Treatment Gives Benefit in First Line REFERENCE: ABSTRACT 3, ASCO Annual Meeting Chicago June 1-5, 2007 BERNARD ESCUDIER, G

Ben Slotman Roy Herbst Prophylactic Cranial Irradiation: Fewer Brain Metastases, Longer Survival for Patients with Small Cell Lung Cancer REFERENCE: ABSTRACT 4, ASCO Annual Meeting Chicago June 1-5, 2

Lawrence Wickerham Invasive Breast Cancer Chemoprevention Trials Assessed REFERENCE: ABSTRACT Special Session; American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles LAW